| Cheplapharm Schweiz GmbH - Sequase XR 300 mg, Retardtabletten | | 63255 | | 04 | | Sequase XR 300 mg | | Retardtabletten | | N05AH04 | | Quetiapin | | 01.10.2013 | | |
| | Composition | | quetiapinum 300 mg ut quetiapini fumaras 345.38 mg, lactosum monohydricum 49.31 mg, cellulosum microcristallinum, natrii citras dihydricus corresp. natrium 23.451 mg, hypromellosum, magnesii stearas, Überzug: hypromellosum, macrogolum 400, E 171, E 172 (flavum), pro compresso obducto. | | Packungsbestandteile | | Comprimés retards | | | | | Principe actif | Concentr. |
|---|
| Quetiapine | 300 mg |
| | BAG: Principe actif | Concentr. |
|---|
| Quetiapine | 300 mg |
| | | | Agents auxilliaires | Concentr. | informations additionels |
|---|
| (Flavum) | | | | Cellulosum Microcristallinum | | | | E 171 | | color. | | E 172 | | color. | | Hypromellosum | | Überzug | | Lactose Monohydrate | 49.31 mg | | | Macrogol | 400 | | | Magnesii Stearas | | | | Natrii Citras Dihydricus | | | | Pro Compresso Obducto | | |
| |
| |
|
